1623767-11-2

Basic information

• Product Name: (R)-4-(3-(4-chloro-3-methoxyphenyl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepin-1-yl)-2,6-dimethylpyridine 1-oxide
• Synonyms: (R)-4-(3-(4-chloro-3-methoxyphenyl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepin-1-yl)-2,6-dimethylpyridine 1-oxide
• CAS NO: 1623767-11-2
• Molecular Weight: 413.904
• Mol File: 1623767-11-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (R)-4-(3-(4-chloro-3-methoxyphenyl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepin-1-yl)-2,6-dimethylpyridine 1-oxide(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-4-(3-(4-chloro-3-methoxyphenyl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepin-1-yl)-2,6-dimethylpyridine 1-oxide(1623767-11-2)
• EPA Substance Registry System: (R)-4-(3-(4-chloro-3-methoxyphenyl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepin-1-yl)-2,6-dimethylpyridine 1-oxide(1623767-11-2)

Safety Data

• Hazardous Substances Data: 1623767-11-2(Hazardous Substances Data)

Upstream product

• 846548-44-5 (2,6-dimethylpyridine-4-yl)boronic acid 
• 1623766-33-5 (R)-5-methoxy-2-methyl-2,3,6,7-tetrahydro-1,4-oxazepine 
• 1623766-34-6 (R)-2-methyl-1,4-oxazepan-5-one 
• 1623766-32-4 (R)-4-(2,4-dimethoxybenzyl)-2-methyl-1,4-oxazepan-5-one 
• 1623766-31-3 (R)-4-(2,4-dimethoxybenzyl)-2-methyl-3,4-dihydro-1,4-oxazepin-5(2H)-one 
• 1623766-30-2 (R)-N-(2,4-dimethoxybenzyl)-N-(2-hydroxypropyl)-3,3-dimethoxypropanamide 
• 1623763-83-6 (R)-3-(4-chloro-3-methoxyphenyl)-1-(2,6-dimethylpyridin-4-yl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine 

Downstream Products

• 1623767-10-1 (R)-(4-(3-(4-chloro-3-methoxyphenyl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepin-1-yl)-6-methylpyridin-2-yl)methanol 
• 1623763-95-0 (R)-3-(4-chloro-3-methoxyphenyl)-1-(2-(fluoromethyl)-6-methylpyridin-4-yl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine 

Relevant articles and documents

Tetrahydroimidazo(1,5-D)[1,4]Oxazepine Derivative

A compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof works as an mGluR2 antagonist, and is applicable as a therapeutic agent for neurological disorders related to glutamate dysfunction and diseases involving th